User login
Senate approves $2 billion NIH increase
AGA applauds Congress for recognizing the need to sustain the momentum for NIH funding and to ensure that it has the purchasing power it needs to attract the best and brightest scientists to pursue careers in research.
The Senate approved the fiscal year (FY) 2019 Labor-HHS-Education Appropriations bill that included a $2 billion increase in funding for the National Institutes of Health (NIH). This increase represents a 5.5% increase in NIH funding, on top of the 8.8% increase that NIH received as part of the Omnibus Appropriations bill for FY 2018. The funding also represents the largest increase in funding since the doubling period (FY 1999-FY 2003), and enabled NIH to support 1,149 additional research grants.
The $2 billion increase included in the Senate bill reflects the necessary funding that NIH needs to keep pace with medical research inflation. This increase will enable NIH to continue to fund innovative research, improve the quality of care for millions of Americans, and maintain U.S. global leadership in medical research. The House has recommended a $1.1 billion increase in NIH funding, but AGA will be pushing for the $2 billion increase. House and Senate leaders will be working to negotiate an agreement on funding.
AGA applauds Congress for recognizing the need to sustain the momentum for NIH funding and to ensure that it has the purchasing power it needs to attract the best and brightest scientists to pursue careers in research.
The Senate approved the fiscal year (FY) 2019 Labor-HHS-Education Appropriations bill that included a $2 billion increase in funding for the National Institutes of Health (NIH). This increase represents a 5.5% increase in NIH funding, on top of the 8.8% increase that NIH received as part of the Omnibus Appropriations bill for FY 2018. The funding also represents the largest increase in funding since the doubling period (FY 1999-FY 2003), and enabled NIH to support 1,149 additional research grants.
The $2 billion increase included in the Senate bill reflects the necessary funding that NIH needs to keep pace with medical research inflation. This increase will enable NIH to continue to fund innovative research, improve the quality of care for millions of Americans, and maintain U.S. global leadership in medical research. The House has recommended a $1.1 billion increase in NIH funding, but AGA will be pushing for the $2 billion increase. House and Senate leaders will be working to negotiate an agreement on funding.
AGA applauds Congress for recognizing the need to sustain the momentum for NIH funding and to ensure that it has the purchasing power it needs to attract the best and brightest scientists to pursue careers in research.
The Senate approved the fiscal year (FY) 2019 Labor-HHS-Education Appropriations bill that included a $2 billion increase in funding for the National Institutes of Health (NIH). This increase represents a 5.5% increase in NIH funding, on top of the 8.8% increase that NIH received as part of the Omnibus Appropriations bill for FY 2018. The funding also represents the largest increase in funding since the doubling period (FY 1999-FY 2003), and enabled NIH to support 1,149 additional research grants.
The $2 billion increase included in the Senate bill reflects the necessary funding that NIH needs to keep pace with medical research inflation. This increase will enable NIH to continue to fund innovative research, improve the quality of care for millions of Americans, and maintain U.S. global leadership in medical research. The House has recommended a $1.1 billion increase in NIH funding, but AGA will be pushing for the $2 billion increase. House and Senate leaders will be working to negotiate an agreement on funding.
Top patient cases
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community to seek advice from fellow GIs on therapy and disease management options, best practices, and diagnoses.
In case you missed it, here are the most popular clinical cases shared in the forum recently:
1. Eosinophilic esophagitis and stricture
A tight stricture in the mid-esophagus of a 25-year-old patient prevented the physician from passing the scope on multiple occasions within 5 weeks.
2. Behcet’s
A 41-year-old patient with Behcet’s disease and celiac disease originally reported joint pain and diarrhea, which subsided after treatment with prednisone and sulfasalazine. Despite a limited diet and therapeutic levels of Humira, her symptoms resurfaced 6 months later with loose stools and urgency.
3. Ectopic varices with portal vein thrombosis
This case involves a 49-year-old male who developed necrotizing pancreatitis due to microlithiasis in 2008, followed by pyrexia with three pyogenic liver abscesses this past May. The attending physician solicited advice from the GI community on management of this patient’s portal hypertension.
4. Firefighters at higher CRC risk?
Join this informative discussion about a reported “1.21 times greater risk” for colorectal cancer in firefighters, and increased screening for this demographic.
More clinical cases and discussions are at https://community.gastro.org/discussions.
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community to seek advice from fellow GIs on therapy and disease management options, best practices, and diagnoses.
In case you missed it, here are the most popular clinical cases shared in the forum recently:
1. Eosinophilic esophagitis and stricture
A tight stricture in the mid-esophagus of a 25-year-old patient prevented the physician from passing the scope on multiple occasions within 5 weeks.
2. Behcet’s
A 41-year-old patient with Behcet’s disease and celiac disease originally reported joint pain and diarrhea, which subsided after treatment with prednisone and sulfasalazine. Despite a limited diet and therapeutic levels of Humira, her symptoms resurfaced 6 months later with loose stools and urgency.
3. Ectopic varices with portal vein thrombosis
This case involves a 49-year-old male who developed necrotizing pancreatitis due to microlithiasis in 2008, followed by pyrexia with three pyogenic liver abscesses this past May. The attending physician solicited advice from the GI community on management of this patient’s portal hypertension.
4. Firefighters at higher CRC risk?
Join this informative discussion about a reported “1.21 times greater risk” for colorectal cancer in firefighters, and increased screening for this demographic.
More clinical cases and discussions are at https://community.gastro.org/discussions.
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community to seek advice from fellow GIs on therapy and disease management options, best practices, and diagnoses.
In case you missed it, here are the most popular clinical cases shared in the forum recently:
1. Eosinophilic esophagitis and stricture
A tight stricture in the mid-esophagus of a 25-year-old patient prevented the physician from passing the scope on multiple occasions within 5 weeks.
2. Behcet’s
A 41-year-old patient with Behcet’s disease and celiac disease originally reported joint pain and diarrhea, which subsided after treatment with prednisone and sulfasalazine. Despite a limited diet and therapeutic levels of Humira, her symptoms resurfaced 6 months later with loose stools and urgency.
3. Ectopic varices with portal vein thrombosis
This case involves a 49-year-old male who developed necrotizing pancreatitis due to microlithiasis in 2008, followed by pyrexia with three pyogenic liver abscesses this past May. The attending physician solicited advice from the GI community on management of this patient’s portal hypertension.
4. Firefighters at higher CRC risk?
Join this informative discussion about a reported “1.21 times greater risk” for colorectal cancer in firefighters, and increased screening for this demographic.
More clinical cases and discussions are at https://community.gastro.org/discussions.
A Gift to the AGA Research Foundation in Your Will
A simple, flexible and versatile way to ensure the AGA Research Foundation can continue to help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow is through a gift in your will or living trust, known as a charitable bequest.
To make a charitable bequest, you need a current will or living trust. Your gift can be made as a percentage of your estate. Or you can make a specific bequest by giving a certain amount of cash, securities or property. After your lifetime, the Foundation receives your gift.
Including the AGA Research Foundation in your will is a popular gift to give because it is:
• Affordable. The actual giving of your gift occurs after your lifetime, so your current income is not affected.
• Flexible. Until your will goes into effect, you are free to alter your plans or change your mind.
• Versatile. You can give a specific item, a set amount of money or a percentage of your estate. You can also make your gift contingent upon certain events.
We hope you’ll consider including a gift to the AGA Research Foundation in your will or liv-ing trust. It’s simple – just a few sentences in your will or trust are all that is needed. The official bequest language for the AGA Research Foundation is: “I, [name], of [city, state, ZIP], give, devise and bequeath to the AGA Research Foundation [written amount or per-centage of the estate or description of property] for its unrestricted use and purpose.”
By including a gift to the AGA Research Foundation in your will, you can help fill the funding gap and protect the next generation of investigators.
For more information, visit http://gastro.planmylegacy.org/ or contact us at [email protected].
A simple, flexible and versatile way to ensure the AGA Research Foundation can continue to help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow is through a gift in your will or living trust, known as a charitable bequest.
To make a charitable bequest, you need a current will or living trust. Your gift can be made as a percentage of your estate. Or you can make a specific bequest by giving a certain amount of cash, securities or property. After your lifetime, the Foundation receives your gift.
Including the AGA Research Foundation in your will is a popular gift to give because it is:
• Affordable. The actual giving of your gift occurs after your lifetime, so your current income is not affected.
• Flexible. Until your will goes into effect, you are free to alter your plans or change your mind.
• Versatile. You can give a specific item, a set amount of money or a percentage of your estate. You can also make your gift contingent upon certain events.
We hope you’ll consider including a gift to the AGA Research Foundation in your will or liv-ing trust. It’s simple – just a few sentences in your will or trust are all that is needed. The official bequest language for the AGA Research Foundation is: “I, [name], of [city, state, ZIP], give, devise and bequeath to the AGA Research Foundation [written amount or per-centage of the estate or description of property] for its unrestricted use and purpose.”
By including a gift to the AGA Research Foundation in your will, you can help fill the funding gap and protect the next generation of investigators.
For more information, visit http://gastro.planmylegacy.org/ or contact us at [email protected].
A simple, flexible and versatile way to ensure the AGA Research Foundation can continue to help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow is through a gift in your will or living trust, known as a charitable bequest.
To make a charitable bequest, you need a current will or living trust. Your gift can be made as a percentage of your estate. Or you can make a specific bequest by giving a certain amount of cash, securities or property. After your lifetime, the Foundation receives your gift.
Including the AGA Research Foundation in your will is a popular gift to give because it is:
• Affordable. The actual giving of your gift occurs after your lifetime, so your current income is not affected.
• Flexible. Until your will goes into effect, you are free to alter your plans or change your mind.
• Versatile. You can give a specific item, a set amount of money or a percentage of your estate. You can also make your gift contingent upon certain events.
We hope you’ll consider including a gift to the AGA Research Foundation in your will or liv-ing trust. It’s simple – just a few sentences in your will or trust are all that is needed. The official bequest language for the AGA Research Foundation is: “I, [name], of [city, state, ZIP], give, devise and bequeath to the AGA Research Foundation [written amount or per-centage of the estate or description of property] for its unrestricted use and purpose.”
By including a gift to the AGA Research Foundation in your will, you can help fill the funding gap and protect the next generation of investigators.
For more information, visit http://gastro.planmylegacy.org/ or contact us at [email protected].
Register for October Coding Course
Learn to use the correct codes, use all the codes necessary and submit everything properly the first time at the SVS Coding and Reimbursement Workshop, Oct. 19 and 20 at the Renaissance Chicago Downtown Hotel in Chicago. These skills learned can help vascular surgeons avoid an audit, as correct coding lessens the risk for one. And an audit costs staff time and money no matter what the outcome. Book hotel rooms by Sept. 27 to receive the special room rate for participants.
Learn to use the correct codes, use all the codes necessary and submit everything properly the first time at the SVS Coding and Reimbursement Workshop, Oct. 19 and 20 at the Renaissance Chicago Downtown Hotel in Chicago. These skills learned can help vascular surgeons avoid an audit, as correct coding lessens the risk for one. And an audit costs staff time and money no matter what the outcome. Book hotel rooms by Sept. 27 to receive the special room rate for participants.
Learn to use the correct codes, use all the codes necessary and submit everything properly the first time at the SVS Coding and Reimbursement Workshop, Oct. 19 and 20 at the Renaissance Chicago Downtown Hotel in Chicago. These skills learned can help vascular surgeons avoid an audit, as correct coding lessens the risk for one. And an audit costs staff time and money no matter what the outcome. Book hotel rooms by Sept. 27 to receive the special room rate for participants.
Bridge Grant Applications Due Oct. 1
Applications are due Oct. 1 for the SVS Foundation's new Bridge Grant, which provides funding from one grant to another. The grant targets those investigators with previous national funding for basic research, such as an NIH R01 grant, and who applied for another R01 grant but did not receive a high enough priority score to be funded again. Apply today.
Applications are due Oct. 1 for the SVS Foundation's new Bridge Grant, which provides funding from one grant to another. The grant targets those investigators with previous national funding for basic research, such as an NIH R01 grant, and who applied for another R01 grant but did not receive a high enough priority score to be funded again. Apply today.
Applications are due Oct. 1 for the SVS Foundation's new Bridge Grant, which provides funding from one grant to another. The grant targets those investigators with previous national funding for basic research, such as an NIH R01 grant, and who applied for another R01 grant but did not receive a high enough priority score to be funded again. Apply today.
Dr. Valerie W. Rusch to receive ACS Distinguished Service Award
The Board of Regents of the American College of Surgeons (ACS) has selected Valerie W. Rusch, MD, FACS, an esteemed thoracic surgeon in New York, NY, as the recipient of the 2018 Distinguished Service Award (DSA)--the College's highest honor. The Board of Regents will present the award to Dr. Rusch, vice-chair, clinical research, department of surgery; Miner Family Chair in Intrathoracic Cancers; attending surgeon, thoracic service, department of surgery, Memorial Sloan-Kettering Cancer Center; and professor of surgery, Weill Cornell Medical College, New York, NY, at the Convocation ceremony at 6:00 pm October 21 at the Clinical Congress 2018 in Boston, MA.
The Board of Regents is presenting the DSA to Dr. Rusch for "her exemplary leadership of many professional organizations and as a mentor, teacher, and trainer of the next generation of surgeons in clinical trial development and her dedication to expand access to surgical care to underserved global populations," according to the award citation.
The award also is being presented to Dr. Rusch "in admiration of her natural leadership, integrity, vision, and steadfast commitment to the College's initiatives and principles, serving as a role model to surgeons everywhere to always do the right thing for patients."
Leadership in the ACS
An ACS Fellow since 1986, Dr. Rusch has led several prominent ACS bodies, including serving as Chair of the Board of Governors (2006−2008) and Board of Regents (2015−2016). A Regent from 2008 to 2017, she chaired the Central Judiciary Committee (2009–2013), the Program Committee (2011–2017), the Board of Regents Nominating Committee (2011–2012), and the Committee on Global Engagement (2016−2017). She served on the Board of Regents Honors Committee (2012−2016), Executive Committee (2013−2016), and Finance Committee (2014−2016).
In addition, she has been a member of the College’s Advisory Council for Cardiothoracic Surgery (2002−2017), International Relations Committee (2007−2013, Executive Committee, 2009−2012), Commission on Cancer Executive Committee (2012−2017), Scholarships Committee (2008−2012), and Research and Optimal Patient Care Committee (2008−2015).
Renowned thoracic surgeon
Dr. Rusch specializes in the diagnosis and treatment of patients with cancers of the lung, airways (trachea, bronchi), esophagus, mediastinum, chest wall, and pleura (malignant pleural mesothelioma). She was among the first women in the U.S. to be board certified in thoracic surgery.
For more than 30 years, she has emphasized a multidisciplinary approach to treating patients with thoracic malignancy. Her research has focused on the molecular behaviors of asbestos cancers and the genetic tendencies of lung cancer as a means to identify certain cancers in the earlier stages.
Dr. Rusch has been a leader in national and international clinical trials for the treatment of thoracic malignancies and played a pivotal role in establishing the ACS Oncology Group--now the ACS Clinical Research Program. Among her many honors, in 2007, Dr. Rusch received the Thoracic Surgery Foundation for Research and Education Socrates Award, and in 2012, the Association of Women Surgeons awarded her the Nina Starr Braunwald Award for lifetime contributions to the advancement of women in surgery.
She has held 25 visiting professorships and lectureships and given more than 300 major lectures on thoracic cancers at medical conferences around the world. Her curriculum vitae boasts more than 400 peer-reviewed publications.
In addition to the ACS, Dr. Rusch has been a leader of other surgical organizations. More specifically, she served as chair of the American Board of Thoracic Surgery, chair of the Lung and Esophagus Task Force of the American Joint Commission on Cancer, and chair of the Mesothelioma Subcommittee of the International Association for the Study of Lung Cancer Staging Committee.
Dr. Rusch is fluent in both French and English, having graduated from the Lycée Français de New York. She graduated from Vassar College, Poughkeepsie, NY, with a degree in biochemistry. She earned her medical degree from the Columbia University College of Physicians and Surgeons, New York, and she completed surgical residency training in general surgery and thoracic surgery at the University of Washington, Seattle, followed by a fellowship at the University of Texas MD Anderson Cancer Center, Houston.
The Board of Regents of the American College of Surgeons (ACS) has selected Valerie W. Rusch, MD, FACS, an esteemed thoracic surgeon in New York, NY, as the recipient of the 2018 Distinguished Service Award (DSA)--the College's highest honor. The Board of Regents will present the award to Dr. Rusch, vice-chair, clinical research, department of surgery; Miner Family Chair in Intrathoracic Cancers; attending surgeon, thoracic service, department of surgery, Memorial Sloan-Kettering Cancer Center; and professor of surgery, Weill Cornell Medical College, New York, NY, at the Convocation ceremony at 6:00 pm October 21 at the Clinical Congress 2018 in Boston, MA.
The Board of Regents is presenting the DSA to Dr. Rusch for "her exemplary leadership of many professional organizations and as a mentor, teacher, and trainer of the next generation of surgeons in clinical trial development and her dedication to expand access to surgical care to underserved global populations," according to the award citation.
The award also is being presented to Dr. Rusch "in admiration of her natural leadership, integrity, vision, and steadfast commitment to the College's initiatives and principles, serving as a role model to surgeons everywhere to always do the right thing for patients."
Leadership in the ACS
An ACS Fellow since 1986, Dr. Rusch has led several prominent ACS bodies, including serving as Chair of the Board of Governors (2006−2008) and Board of Regents (2015−2016). A Regent from 2008 to 2017, she chaired the Central Judiciary Committee (2009–2013), the Program Committee (2011–2017), the Board of Regents Nominating Committee (2011–2012), and the Committee on Global Engagement (2016−2017). She served on the Board of Regents Honors Committee (2012−2016), Executive Committee (2013−2016), and Finance Committee (2014−2016).
In addition, she has been a member of the College’s Advisory Council for Cardiothoracic Surgery (2002−2017), International Relations Committee (2007−2013, Executive Committee, 2009−2012), Commission on Cancer Executive Committee (2012−2017), Scholarships Committee (2008−2012), and Research and Optimal Patient Care Committee (2008−2015).
Renowned thoracic surgeon
Dr. Rusch specializes in the diagnosis and treatment of patients with cancers of the lung, airways (trachea, bronchi), esophagus, mediastinum, chest wall, and pleura (malignant pleural mesothelioma). She was among the first women in the U.S. to be board certified in thoracic surgery.
For more than 30 years, she has emphasized a multidisciplinary approach to treating patients with thoracic malignancy. Her research has focused on the molecular behaviors of asbestos cancers and the genetic tendencies of lung cancer as a means to identify certain cancers in the earlier stages.
Dr. Rusch has been a leader in national and international clinical trials for the treatment of thoracic malignancies and played a pivotal role in establishing the ACS Oncology Group--now the ACS Clinical Research Program. Among her many honors, in 2007, Dr. Rusch received the Thoracic Surgery Foundation for Research and Education Socrates Award, and in 2012, the Association of Women Surgeons awarded her the Nina Starr Braunwald Award for lifetime contributions to the advancement of women in surgery.
She has held 25 visiting professorships and lectureships and given more than 300 major lectures on thoracic cancers at medical conferences around the world. Her curriculum vitae boasts more than 400 peer-reviewed publications.
In addition to the ACS, Dr. Rusch has been a leader of other surgical organizations. More specifically, she served as chair of the American Board of Thoracic Surgery, chair of the Lung and Esophagus Task Force of the American Joint Commission on Cancer, and chair of the Mesothelioma Subcommittee of the International Association for the Study of Lung Cancer Staging Committee.
Dr. Rusch is fluent in both French and English, having graduated from the Lycée Français de New York. She graduated from Vassar College, Poughkeepsie, NY, with a degree in biochemistry. She earned her medical degree from the Columbia University College of Physicians and Surgeons, New York, and she completed surgical residency training in general surgery and thoracic surgery at the University of Washington, Seattle, followed by a fellowship at the University of Texas MD Anderson Cancer Center, Houston.
The Board of Regents of the American College of Surgeons (ACS) has selected Valerie W. Rusch, MD, FACS, an esteemed thoracic surgeon in New York, NY, as the recipient of the 2018 Distinguished Service Award (DSA)--the College's highest honor. The Board of Regents will present the award to Dr. Rusch, vice-chair, clinical research, department of surgery; Miner Family Chair in Intrathoracic Cancers; attending surgeon, thoracic service, department of surgery, Memorial Sloan-Kettering Cancer Center; and professor of surgery, Weill Cornell Medical College, New York, NY, at the Convocation ceremony at 6:00 pm October 21 at the Clinical Congress 2018 in Boston, MA.
The Board of Regents is presenting the DSA to Dr. Rusch for "her exemplary leadership of many professional organizations and as a mentor, teacher, and trainer of the next generation of surgeons in clinical trial development and her dedication to expand access to surgical care to underserved global populations," according to the award citation.
The award also is being presented to Dr. Rusch "in admiration of her natural leadership, integrity, vision, and steadfast commitment to the College's initiatives and principles, serving as a role model to surgeons everywhere to always do the right thing for patients."
Leadership in the ACS
An ACS Fellow since 1986, Dr. Rusch has led several prominent ACS bodies, including serving as Chair of the Board of Governors (2006−2008) and Board of Regents (2015−2016). A Regent from 2008 to 2017, she chaired the Central Judiciary Committee (2009–2013), the Program Committee (2011–2017), the Board of Regents Nominating Committee (2011–2012), and the Committee on Global Engagement (2016−2017). She served on the Board of Regents Honors Committee (2012−2016), Executive Committee (2013−2016), and Finance Committee (2014−2016).
In addition, she has been a member of the College’s Advisory Council for Cardiothoracic Surgery (2002−2017), International Relations Committee (2007−2013, Executive Committee, 2009−2012), Commission on Cancer Executive Committee (2012−2017), Scholarships Committee (2008−2012), and Research and Optimal Patient Care Committee (2008−2015).
Renowned thoracic surgeon
Dr. Rusch specializes in the diagnosis and treatment of patients with cancers of the lung, airways (trachea, bronchi), esophagus, mediastinum, chest wall, and pleura (malignant pleural mesothelioma). She was among the first women in the U.S. to be board certified in thoracic surgery.
For more than 30 years, she has emphasized a multidisciplinary approach to treating patients with thoracic malignancy. Her research has focused on the molecular behaviors of asbestos cancers and the genetic tendencies of lung cancer as a means to identify certain cancers in the earlier stages.
Dr. Rusch has been a leader in national and international clinical trials for the treatment of thoracic malignancies and played a pivotal role in establishing the ACS Oncology Group--now the ACS Clinical Research Program. Among her many honors, in 2007, Dr. Rusch received the Thoracic Surgery Foundation for Research and Education Socrates Award, and in 2012, the Association of Women Surgeons awarded her the Nina Starr Braunwald Award for lifetime contributions to the advancement of women in surgery.
She has held 25 visiting professorships and lectureships and given more than 300 major lectures on thoracic cancers at medical conferences around the world. Her curriculum vitae boasts more than 400 peer-reviewed publications.
In addition to the ACS, Dr. Rusch has been a leader of other surgical organizations. More specifically, she served as chair of the American Board of Thoracic Surgery, chair of the Lung and Esophagus Task Force of the American Joint Commission on Cancer, and chair of the Mesothelioma Subcommittee of the International Association for the Study of Lung Cancer Staging Committee.
Dr. Rusch is fluent in both French and English, having graduated from the Lycée Français de New York. She graduated from Vassar College, Poughkeepsie, NY, with a degree in biochemistry. She earned her medical degree from the Columbia University College of Physicians and Surgeons, New York, and she completed surgical residency training in general surgery and thoracic surgery at the University of Washington, Seattle, followed by a fellowship at the University of Texas MD Anderson Cancer Center, Houston.
CHEST keynote to bridge the gap between generations
Scott Zimmer, a product of generation X, went through college with a passion for public speaking, as well as a deep interest in the generational divide. In 2013, he began working for a company called BridgeWorks and so began his career as one of three speakers at this firm of “generational junkies and trend spotters.”
Founded in 1998, Bridgeworks strives to bridge the generational gaps that are found in all workplaces through research, keynote speakers, workshops, blogs, training, trivia, and more. Bridgeworks is a team of 13 people coming from the baby boomer generation down to millennials on the cusp of being classified with generation Z (gen edgers, as Zimmer calls them). Each team member has their own interesting and diverse background with a passion for the topic of generations, and everyone engages this passion by conducting research with the BridgeWorks team.
There are generational clashes in every single industry, according to Zimmer. Just at BridgeWorks, he even notices when simply sending a text he perceives as “normal” to one of his millennial coworkers, that it is sometimes received as curt and leaves the recipient concerned that they have done something to offend him. This topic is not foreign to anyone— everyone has had a moment of saying “kids these days,” or “ugh, old people.” Because of this, Zimmer starts every session knowing that each person will leave with relevant insights and actionable takeaways.
Zimmer also loves to integrate nostalgia into his presentations, and working with generational theory at BridgeWorks allows him to do just that in a way that helps drive home points and makes ideas more relatable. “Some people like to say we are all just people and we grow out of certain things. But we develop specific traits and values at an impressionable age, and I love looking at what was happening in our lives during those formative years. What are these shared experiences that will form who we are?” This love of nostalgia set Zimmer up for a great opportunity to develop his own trivia gameshow at BridgeWorks. GenPOP! is an interactive trivia gameshow that pairs members of different generations up and quizzes them on all things pop culture from different decades, while also teaching audience members new things about the people they interact with every day.
“So much goes into who we are and who shows up to the workplace, what effects our behavior, and our motivation,” says Zimmer when asked where his passion for this topic stems. “It could be our gender, the region we grew up in, or birth order, and I personally like looking at it through the lens of these different generations.”
So, what will Zimmer bring to CHEST 2018? During his keynote presentation in San Antonio, Zimmer will examine the generational gaps that are existent in the medical community. “You don’t want your young medical professionals to feel like they are sitting at the ‘kids table’ or being talked down to when they have something to share because they do not have equal experience.”
Each generation and each member of a medical team communicates differently, and understanding those differences and feeling like an equal part of the team is very important. How information is conveyed to patients and medical team members of any age affects how they perceive given information and the level of comfort that is felt by each party. Finding ways to bridge the obvious gaps between the generations is a key component to making any team work efficiently.
Scott Zimmer, a product of generation X, went through college with a passion for public speaking, as well as a deep interest in the generational divide. In 2013, he began working for a company called BridgeWorks and so began his career as one of three speakers at this firm of “generational junkies and trend spotters.”
Founded in 1998, Bridgeworks strives to bridge the generational gaps that are found in all workplaces through research, keynote speakers, workshops, blogs, training, trivia, and more. Bridgeworks is a team of 13 people coming from the baby boomer generation down to millennials on the cusp of being classified with generation Z (gen edgers, as Zimmer calls them). Each team member has their own interesting and diverse background with a passion for the topic of generations, and everyone engages this passion by conducting research with the BridgeWorks team.
There are generational clashes in every single industry, according to Zimmer. Just at BridgeWorks, he even notices when simply sending a text he perceives as “normal” to one of his millennial coworkers, that it is sometimes received as curt and leaves the recipient concerned that they have done something to offend him. This topic is not foreign to anyone— everyone has had a moment of saying “kids these days,” or “ugh, old people.” Because of this, Zimmer starts every session knowing that each person will leave with relevant insights and actionable takeaways.
Zimmer also loves to integrate nostalgia into his presentations, and working with generational theory at BridgeWorks allows him to do just that in a way that helps drive home points and makes ideas more relatable. “Some people like to say we are all just people and we grow out of certain things. But we develop specific traits and values at an impressionable age, and I love looking at what was happening in our lives during those formative years. What are these shared experiences that will form who we are?” This love of nostalgia set Zimmer up for a great opportunity to develop his own trivia gameshow at BridgeWorks. GenPOP! is an interactive trivia gameshow that pairs members of different generations up and quizzes them on all things pop culture from different decades, while also teaching audience members new things about the people they interact with every day.
“So much goes into who we are and who shows up to the workplace, what effects our behavior, and our motivation,” says Zimmer when asked where his passion for this topic stems. “It could be our gender, the region we grew up in, or birth order, and I personally like looking at it through the lens of these different generations.”
So, what will Zimmer bring to CHEST 2018? During his keynote presentation in San Antonio, Zimmer will examine the generational gaps that are existent in the medical community. “You don’t want your young medical professionals to feel like they are sitting at the ‘kids table’ or being talked down to when they have something to share because they do not have equal experience.”
Each generation and each member of a medical team communicates differently, and understanding those differences and feeling like an equal part of the team is very important. How information is conveyed to patients and medical team members of any age affects how they perceive given information and the level of comfort that is felt by each party. Finding ways to bridge the obvious gaps between the generations is a key component to making any team work efficiently.
Scott Zimmer, a product of generation X, went through college with a passion for public speaking, as well as a deep interest in the generational divide. In 2013, he began working for a company called BridgeWorks and so began his career as one of three speakers at this firm of “generational junkies and trend spotters.”
Founded in 1998, Bridgeworks strives to bridge the generational gaps that are found in all workplaces through research, keynote speakers, workshops, blogs, training, trivia, and more. Bridgeworks is a team of 13 people coming from the baby boomer generation down to millennials on the cusp of being classified with generation Z (gen edgers, as Zimmer calls them). Each team member has their own interesting and diverse background with a passion for the topic of generations, and everyone engages this passion by conducting research with the BridgeWorks team.
There are generational clashes in every single industry, according to Zimmer. Just at BridgeWorks, he even notices when simply sending a text he perceives as “normal” to one of his millennial coworkers, that it is sometimes received as curt and leaves the recipient concerned that they have done something to offend him. This topic is not foreign to anyone— everyone has had a moment of saying “kids these days,” or “ugh, old people.” Because of this, Zimmer starts every session knowing that each person will leave with relevant insights and actionable takeaways.
Zimmer also loves to integrate nostalgia into his presentations, and working with generational theory at BridgeWorks allows him to do just that in a way that helps drive home points and makes ideas more relatable. “Some people like to say we are all just people and we grow out of certain things. But we develop specific traits and values at an impressionable age, and I love looking at what was happening in our lives during those formative years. What are these shared experiences that will form who we are?” This love of nostalgia set Zimmer up for a great opportunity to develop his own trivia gameshow at BridgeWorks. GenPOP! is an interactive trivia gameshow that pairs members of different generations up and quizzes them on all things pop culture from different decades, while also teaching audience members new things about the people they interact with every day.
“So much goes into who we are and who shows up to the workplace, what effects our behavior, and our motivation,” says Zimmer when asked where his passion for this topic stems. “It could be our gender, the region we grew up in, or birth order, and I personally like looking at it through the lens of these different generations.”
So, what will Zimmer bring to CHEST 2018? During his keynote presentation in San Antonio, Zimmer will examine the generational gaps that are existent in the medical community. “You don’t want your young medical professionals to feel like they are sitting at the ‘kids table’ or being talked down to when they have something to share because they do not have equal experience.”
Each generation and each member of a medical team communicates differently, and understanding those differences and feeling like an equal part of the team is very important. How information is conveyed to patients and medical team members of any age affects how they perceive given information and the level of comfort that is felt by each party. Finding ways to bridge the obvious gaps between the generations is a key component to making any team work efficiently.
Impact factor news for the journal CHEST®
The journal CHEST® was recently awarded a 2-year impact factor of 7.652, the highest in its history, which equates to a 24% increase over last year’s score. In addition, our 5-year impact factor is 7.854, a 7% increase over last year. With respect to the 2-year factor, CHEST® is ranked 4th out of 33 journals in the Critical Care category and 7th out of 59 journals in the Respiratory System category.
Our recent Eigenfactor places us as the second-highest ranked journal in both respiratory and critical care categories. The Eigenfactor metric adjusts the impact factor by eliminating self-citations and factoring in citations in the top-tier journals.
Congratulations to our journal CHEST® !
The journal CHEST® was recently awarded a 2-year impact factor of 7.652, the highest in its history, which equates to a 24% increase over last year’s score. In addition, our 5-year impact factor is 7.854, a 7% increase over last year. With respect to the 2-year factor, CHEST® is ranked 4th out of 33 journals in the Critical Care category and 7th out of 59 journals in the Respiratory System category.
Our recent Eigenfactor places us as the second-highest ranked journal in both respiratory and critical care categories. The Eigenfactor metric adjusts the impact factor by eliminating self-citations and factoring in citations in the top-tier journals.
Congratulations to our journal CHEST® !
The journal CHEST® was recently awarded a 2-year impact factor of 7.652, the highest in its history, which equates to a 24% increase over last year’s score. In addition, our 5-year impact factor is 7.854, a 7% increase over last year. With respect to the 2-year factor, CHEST® is ranked 4th out of 33 journals in the Critical Care category and 7th out of 59 journals in the Respiratory System category.
Our recent Eigenfactor places us as the second-highest ranked journal in both respiratory and critical care categories. The Eigenfactor metric adjusts the impact factor by eliminating self-citations and factoring in citations in the top-tier journals.
Congratulations to our journal CHEST® !
CHEST NetWorks
Palliative and End-of-Life Care
Patient-tailored goals-of-care discussions: Is this the new standard?
Goals-of-care discussions can be challenging conversations for even the most seasoned physicians. The challenge often is not just the timing but also knowing how to stitch together the content of the discussion. In most cases, physicians have minimal prior knowledge of patient and family preferences, and this adds to the complexity. In addition, the majority of these discussions happen in the inpatient setting (Mack et al. Ann Intern Med. 2012;156[3]:204) where the acuity of the illness adds to the barriers of effective communication (Fulmer et al. J Am Geriatr Soc. 2018;May 23. doi: 10.1111/jgs.15374. [Epub ahead of print]). Can these discussions be tailored to suit individual patient needs and can such attempts better goals-of-care communication? A recent publication by Curtis et al in JAMA Internal Medicine (2018;178[7]:930) attempts to shed light on these unanswered questions and provide physician guidance to better engage in these critical discussions. The cluster-randomized trial included both clinicians and patients. Patients were sent a survey assessing their individual preferences, and physicians were given a summary and communication tips based on these preferences (Jumpstart-Tips). This simple, cost-effective yet scalable intervention was able to improve the frequency, documentation, and patient-assessed quality of goals-of-care discussions in an outpatient setting. In addition, the delivery of goal-concordant care was increased at 3 months in the subgroup of patients with stable goals. A notable limitation of this study was the low participation among physicians. Further studies will be needed to further dissect the characteristics of participating and nonparticipating physicians. Research will also be needed to ascertain how to seamlessly integrate this into health-care delivery. But one irrefutable point is that interventions to improve communication hold the key to better end-of-life care delivery for our patients with serious illnesses. Drs. Paladino and Bernacki have aptly noted in their commentary (JAMA Intern Med. 2018;178[7]:940): “In the age of precision medicine, one can imagine a future of precision communication, where we….provide customized direction for clinicians to begin these discussions based on patient-specific needs.” One question remains. Will this be the new standard? The answer lies with us, the clinicians. My answer to this is a resounding “Yes,” and I hope early adopters will lead the way and prove me right.
Shine Raju, MD, MBBS
Steering Committee Member
Respiratory Care
Prevention of health-care professional errors in use of inhalers
Asthma affects approximately 300 million people worldwide. The 2018 Global Initiative for Asthma (GINA) guidelines recommend assessing the patient’s inhaler technique on a regular basis (www.ginasthma.org. Updated 2018. Accessed August 1, 2018).
The pressurized metered-dose inhaler (pMDI) and dry powder inhaler (DPI) are the most common aerosolized medication delivery devices.
Proper inhaler technique optimizes delivery of medication, and patients rely on a variety of their health-care providers (HCP) to teach them to use the devices. Unfortunately, evidence demonstrates patients are unable to use their inhalers properly (Sanchis et al. Chest. 2016;150[2]:394). Improper and inadequate inhaler technique is commonly associated with poor disease control, exacerbations, hospitalization stays, and need for systemic corticosteroids and antibiotic therapy (Capanoglu et al. J Asthma. 2015;52[8]:838; Levy et al. Prim Care Respir J. 2013;22:406; Westerik et al. J Asthma. 2015;53[3]:1).
Incorrect inhaler use is attributed to the design of the device, poor patient understanding, and HCPs having insufficient knowledge of the inhalers and performed the correct inhaled technique 15.5% of the time (Plaza et al. J Allergy Clin Immunol Prac. 2018;6[3]:987).
Health-care providers who are directly responsible for managing patients with pulmonary disease must have knowledge of correct inhaler techniques to effectively teach patients and properly assess their use of these devices. The quality of the HCP instruction to the patient is key to reducing poor inhaler technique (Klijn et al. NPJ Prim Care Respir Med. 2017;;27[1]:24. doi: 10.1038/s41533-017-0022-1). Targeted inhaler technique educational programs for HCPs have been shown to improve clinical outcomes of patients with asthma (Myers. Respir Care. 2015;60[8]:1190). The Respiratory Care NetWork is developing HCP and patient handouts for each aerosol delivery device which may be available in early 2019.
De De Gardner, DrPH, RRT-NPS, FCCP
Steering Committee Member
Sleep Medicine
Pediatric Sleep Disorders
The Sleep Medicine Network has worked hard to contribute to the CHEST 2018 exciting program of events by highlighting hot topics, discussing clinical controversies, and presenting challenging cases in sleep medicine. The goal of the Sleep Medicine Network has been to design content relevant to the diverse audience attending CHEST in San Antonio this year.
This goal includes topics relevant to pediatric sleep medicine. Why is this important to the larger audience at CHEST? Demand for pediatric sleep physicians significantly out paces access in many areas of this country (Phillips et al. Am J Respir Crit Care Med. 2015;192[8]:915). Adult sleep physicians may treat older children or adolescents in their practice, they may care for medically complex children when they transition to adulthood, and they may be asked for advice regarding the sleep concerns of children of their friends and colleagues. Sleep problems in children are common and may affect up to a quarter of children at some point during their lifetime (Owens. Prim Care. 2008;35[3]:533). The entire household is affected when children are not receiving adequate sleep; the sleep of their caregivers and family members is impacted. While many similarities exist between adult and pediatric sleep medicine, physicians who regularly care for children need to be aware of the important differences in the evaluation and treatment of pediatric sleep disorders.
How else can we connect with your practice? If you have an important topic you would like considered for CHEST 2019 please seek out the Sleep Medicine Network meeting in San Antonio, so we can continue to generate relevant content for your practice.
Julie Baughn, MD
Steering Committee Member
Palliative and End-of-Life Care
Patient-tailored goals-of-care discussions: Is this the new standard?
Goals-of-care discussions can be challenging conversations for even the most seasoned physicians. The challenge often is not just the timing but also knowing how to stitch together the content of the discussion. In most cases, physicians have minimal prior knowledge of patient and family preferences, and this adds to the complexity. In addition, the majority of these discussions happen in the inpatient setting (Mack et al. Ann Intern Med. 2012;156[3]:204) where the acuity of the illness adds to the barriers of effective communication (Fulmer et al. J Am Geriatr Soc. 2018;May 23. doi: 10.1111/jgs.15374. [Epub ahead of print]). Can these discussions be tailored to suit individual patient needs and can such attempts better goals-of-care communication? A recent publication by Curtis et al in JAMA Internal Medicine (2018;178[7]:930) attempts to shed light on these unanswered questions and provide physician guidance to better engage in these critical discussions. The cluster-randomized trial included both clinicians and patients. Patients were sent a survey assessing their individual preferences, and physicians were given a summary and communication tips based on these preferences (Jumpstart-Tips). This simple, cost-effective yet scalable intervention was able to improve the frequency, documentation, and patient-assessed quality of goals-of-care discussions in an outpatient setting. In addition, the delivery of goal-concordant care was increased at 3 months in the subgroup of patients with stable goals. A notable limitation of this study was the low participation among physicians. Further studies will be needed to further dissect the characteristics of participating and nonparticipating physicians. Research will also be needed to ascertain how to seamlessly integrate this into health-care delivery. But one irrefutable point is that interventions to improve communication hold the key to better end-of-life care delivery for our patients with serious illnesses. Drs. Paladino and Bernacki have aptly noted in their commentary (JAMA Intern Med. 2018;178[7]:940): “In the age of precision medicine, one can imagine a future of precision communication, where we….provide customized direction for clinicians to begin these discussions based on patient-specific needs.” One question remains. Will this be the new standard? The answer lies with us, the clinicians. My answer to this is a resounding “Yes,” and I hope early adopters will lead the way and prove me right.
Shine Raju, MD, MBBS
Steering Committee Member
Respiratory Care
Prevention of health-care professional errors in use of inhalers
Asthma affects approximately 300 million people worldwide. The 2018 Global Initiative for Asthma (GINA) guidelines recommend assessing the patient’s inhaler technique on a regular basis (www.ginasthma.org. Updated 2018. Accessed August 1, 2018).
The pressurized metered-dose inhaler (pMDI) and dry powder inhaler (DPI) are the most common aerosolized medication delivery devices.
Proper inhaler technique optimizes delivery of medication, and patients rely on a variety of their health-care providers (HCP) to teach them to use the devices. Unfortunately, evidence demonstrates patients are unable to use their inhalers properly (Sanchis et al. Chest. 2016;150[2]:394). Improper and inadequate inhaler technique is commonly associated with poor disease control, exacerbations, hospitalization stays, and need for systemic corticosteroids and antibiotic therapy (Capanoglu et al. J Asthma. 2015;52[8]:838; Levy et al. Prim Care Respir J. 2013;22:406; Westerik et al. J Asthma. 2015;53[3]:1).
Incorrect inhaler use is attributed to the design of the device, poor patient understanding, and HCPs having insufficient knowledge of the inhalers and performed the correct inhaled technique 15.5% of the time (Plaza et al. J Allergy Clin Immunol Prac. 2018;6[3]:987).
Health-care providers who are directly responsible for managing patients with pulmonary disease must have knowledge of correct inhaler techniques to effectively teach patients and properly assess their use of these devices. The quality of the HCP instruction to the patient is key to reducing poor inhaler technique (Klijn et al. NPJ Prim Care Respir Med. 2017;;27[1]:24. doi: 10.1038/s41533-017-0022-1). Targeted inhaler technique educational programs for HCPs have been shown to improve clinical outcomes of patients with asthma (Myers. Respir Care. 2015;60[8]:1190). The Respiratory Care NetWork is developing HCP and patient handouts for each aerosol delivery device which may be available in early 2019.
De De Gardner, DrPH, RRT-NPS, FCCP
Steering Committee Member
Sleep Medicine
Pediatric Sleep Disorders
The Sleep Medicine Network has worked hard to contribute to the CHEST 2018 exciting program of events by highlighting hot topics, discussing clinical controversies, and presenting challenging cases in sleep medicine. The goal of the Sleep Medicine Network has been to design content relevant to the diverse audience attending CHEST in San Antonio this year.
This goal includes topics relevant to pediatric sleep medicine. Why is this important to the larger audience at CHEST? Demand for pediatric sleep physicians significantly out paces access in many areas of this country (Phillips et al. Am J Respir Crit Care Med. 2015;192[8]:915). Adult sleep physicians may treat older children or adolescents in their practice, they may care for medically complex children when they transition to adulthood, and they may be asked for advice regarding the sleep concerns of children of their friends and colleagues. Sleep problems in children are common and may affect up to a quarter of children at some point during their lifetime (Owens. Prim Care. 2008;35[3]:533). The entire household is affected when children are not receiving adequate sleep; the sleep of their caregivers and family members is impacted. While many similarities exist between adult and pediatric sleep medicine, physicians who regularly care for children need to be aware of the important differences in the evaluation and treatment of pediatric sleep disorders.
How else can we connect with your practice? If you have an important topic you would like considered for CHEST 2019 please seek out the Sleep Medicine Network meeting in San Antonio, so we can continue to generate relevant content for your practice.
Julie Baughn, MD
Steering Committee Member
Palliative and End-of-Life Care
Patient-tailored goals-of-care discussions: Is this the new standard?
Goals-of-care discussions can be challenging conversations for even the most seasoned physicians. The challenge often is not just the timing but also knowing how to stitch together the content of the discussion. In most cases, physicians have minimal prior knowledge of patient and family preferences, and this adds to the complexity. In addition, the majority of these discussions happen in the inpatient setting (Mack et al. Ann Intern Med. 2012;156[3]:204) where the acuity of the illness adds to the barriers of effective communication (Fulmer et al. J Am Geriatr Soc. 2018;May 23. doi: 10.1111/jgs.15374. [Epub ahead of print]). Can these discussions be tailored to suit individual patient needs and can such attempts better goals-of-care communication? A recent publication by Curtis et al in JAMA Internal Medicine (2018;178[7]:930) attempts to shed light on these unanswered questions and provide physician guidance to better engage in these critical discussions. The cluster-randomized trial included both clinicians and patients. Patients were sent a survey assessing their individual preferences, and physicians were given a summary and communication tips based on these preferences (Jumpstart-Tips). This simple, cost-effective yet scalable intervention was able to improve the frequency, documentation, and patient-assessed quality of goals-of-care discussions in an outpatient setting. In addition, the delivery of goal-concordant care was increased at 3 months in the subgroup of patients with stable goals. A notable limitation of this study was the low participation among physicians. Further studies will be needed to further dissect the characteristics of participating and nonparticipating physicians. Research will also be needed to ascertain how to seamlessly integrate this into health-care delivery. But one irrefutable point is that interventions to improve communication hold the key to better end-of-life care delivery for our patients with serious illnesses. Drs. Paladino and Bernacki have aptly noted in their commentary (JAMA Intern Med. 2018;178[7]:940): “In the age of precision medicine, one can imagine a future of precision communication, where we….provide customized direction for clinicians to begin these discussions based on patient-specific needs.” One question remains. Will this be the new standard? The answer lies with us, the clinicians. My answer to this is a resounding “Yes,” and I hope early adopters will lead the way and prove me right.
Shine Raju, MD, MBBS
Steering Committee Member
Respiratory Care
Prevention of health-care professional errors in use of inhalers
Asthma affects approximately 300 million people worldwide. The 2018 Global Initiative for Asthma (GINA) guidelines recommend assessing the patient’s inhaler technique on a regular basis (www.ginasthma.org. Updated 2018. Accessed August 1, 2018).
The pressurized metered-dose inhaler (pMDI) and dry powder inhaler (DPI) are the most common aerosolized medication delivery devices.
Proper inhaler technique optimizes delivery of medication, and patients rely on a variety of their health-care providers (HCP) to teach them to use the devices. Unfortunately, evidence demonstrates patients are unable to use their inhalers properly (Sanchis et al. Chest. 2016;150[2]:394). Improper and inadequate inhaler technique is commonly associated with poor disease control, exacerbations, hospitalization stays, and need for systemic corticosteroids and antibiotic therapy (Capanoglu et al. J Asthma. 2015;52[8]:838; Levy et al. Prim Care Respir J. 2013;22:406; Westerik et al. J Asthma. 2015;53[3]:1).
Incorrect inhaler use is attributed to the design of the device, poor patient understanding, and HCPs having insufficient knowledge of the inhalers and performed the correct inhaled technique 15.5% of the time (Plaza et al. J Allergy Clin Immunol Prac. 2018;6[3]:987).
Health-care providers who are directly responsible for managing patients with pulmonary disease must have knowledge of correct inhaler techniques to effectively teach patients and properly assess their use of these devices. The quality of the HCP instruction to the patient is key to reducing poor inhaler technique (Klijn et al. NPJ Prim Care Respir Med. 2017;;27[1]:24. doi: 10.1038/s41533-017-0022-1). Targeted inhaler technique educational programs for HCPs have been shown to improve clinical outcomes of patients with asthma (Myers. Respir Care. 2015;60[8]:1190). The Respiratory Care NetWork is developing HCP and patient handouts for each aerosol delivery device which may be available in early 2019.
De De Gardner, DrPH, RRT-NPS, FCCP
Steering Committee Member
Sleep Medicine
Pediatric Sleep Disorders
The Sleep Medicine Network has worked hard to contribute to the CHEST 2018 exciting program of events by highlighting hot topics, discussing clinical controversies, and presenting challenging cases in sleep medicine. The goal of the Sleep Medicine Network has been to design content relevant to the diverse audience attending CHEST in San Antonio this year.
This goal includes topics relevant to pediatric sleep medicine. Why is this important to the larger audience at CHEST? Demand for pediatric sleep physicians significantly out paces access in many areas of this country (Phillips et al. Am J Respir Crit Care Med. 2015;192[8]:915). Adult sleep physicians may treat older children or adolescents in their practice, they may care for medically complex children when they transition to adulthood, and they may be asked for advice regarding the sleep concerns of children of their friends and colleagues. Sleep problems in children are common and may affect up to a quarter of children at some point during their lifetime (Owens. Prim Care. 2008;35[3]:533). The entire household is affected when children are not receiving adequate sleep; the sleep of their caregivers and family members is impacted. While many similarities exist between adult and pediatric sleep medicine, physicians who regularly care for children need to be aware of the important differences in the evaluation and treatment of pediatric sleep disorders.
How else can we connect with your practice? If you have an important topic you would like considered for CHEST 2019 please seek out the Sleep Medicine Network meeting in San Antonio, so we can continue to generate relevant content for your practice.
Julie Baughn, MD
Steering Committee Member
CHEST Keynote: Reflections of a Lifetime Practicing Chest Medicine
Dr. Richard Irwin, the Editor in Chief for the journal CHEST, and Chair of UMass Memorial Medical Center’s Department of Critical Care, has observed the way patient-focused care has evolved through the years. He will be speaking on this topic at the CHEST 2018 opening session on Sunday, October 7.
During Dr. Irwin’s early years at UMass Memorial, the then chairman of Medicine, Dr. James Dalen, a longtime CHEST member who was about to begin his term as CHEST President, strongly encouraged Dr. Irwin to join the organization. By joining the college, Dr. Irwin was able to form strong connections with other influential chest medicine professionals, such as Dr. Jack Weg, a former CHEST President, and Dr. Alfred Soffer – who was the Editor in Chief of CHEST.
While Dr. Irwin was not yet a member of the CHEST community, the college became instrumental in focusing Dr. Irwin’s academic career because of a manuscript that he and colleagues had been working on, titled Cough. A Comprehensive Review. After submitting the early version of his manuscript to ten different journals and being rejected by each one, Dr. Irwin contacted Dr. Soffer and asked him, if he had the time, could he please read it and offer advice. Dr. Soffer, who had a reputation of being a mentor with endless generosity of his time, reviewed the manuscript and worked with Dr. Irwin on the article, leading to its publication in the Archives of Internal Medicine in 1977. Dr. Soffer’s kindness would lead to the start of Dr. Irwin’s 40-year career of studying cough.
Dr. Irwin has been very influential within the CHEST organization throughout his career. In addition to his years as the Editor in Chief of CHEST, he also served on every major CHEST committee and held the office of CHEST President in 2003-2004. “If you want to join a society that has a family-feel to it and focuses on clinical care and education, then CHEST is the place to be.”
Throughout his years as a physician, Dr. Irwin has been interested in the way physicians learn. During his formative years, he says the way he learned was to “see one, do one, teach one.” He gives the example of the flexible fiber-optic bronchoscope, which was developed in Japan in the late 1960s, arriving in the US in 1970. It was a new way of performing bronchoscopy, which led to physicians reading about it, and then putting what they read into action. Now – there are high fidelity simulation instruments and models and a lot of experiential learning prefacing the use of new technologies for patients. We have CHEST to thank for being a leader in experiential learning and an international resource for simulation training.
Dr. Richard Irwin, the Editor in Chief for the journal CHEST, and Chair of UMass Memorial Medical Center’s Department of Critical Care, has observed the way patient-focused care has evolved through the years. He will be speaking on this topic at the CHEST 2018 opening session on Sunday, October 7.
During Dr. Irwin’s early years at UMass Memorial, the then chairman of Medicine, Dr. James Dalen, a longtime CHEST member who was about to begin his term as CHEST President, strongly encouraged Dr. Irwin to join the organization. By joining the college, Dr. Irwin was able to form strong connections with other influential chest medicine professionals, such as Dr. Jack Weg, a former CHEST President, and Dr. Alfred Soffer – who was the Editor in Chief of CHEST.
While Dr. Irwin was not yet a member of the CHEST community, the college became instrumental in focusing Dr. Irwin’s academic career because of a manuscript that he and colleagues had been working on, titled Cough. A Comprehensive Review. After submitting the early version of his manuscript to ten different journals and being rejected by each one, Dr. Irwin contacted Dr. Soffer and asked him, if he had the time, could he please read it and offer advice. Dr. Soffer, who had a reputation of being a mentor with endless generosity of his time, reviewed the manuscript and worked with Dr. Irwin on the article, leading to its publication in the Archives of Internal Medicine in 1977. Dr. Soffer’s kindness would lead to the start of Dr. Irwin’s 40-year career of studying cough.
Dr. Irwin has been very influential within the CHEST organization throughout his career. In addition to his years as the Editor in Chief of CHEST, he also served on every major CHEST committee and held the office of CHEST President in 2003-2004. “If you want to join a society that has a family-feel to it and focuses on clinical care and education, then CHEST is the place to be.”
Throughout his years as a physician, Dr. Irwin has been interested in the way physicians learn. During his formative years, he says the way he learned was to “see one, do one, teach one.” He gives the example of the flexible fiber-optic bronchoscope, which was developed in Japan in the late 1960s, arriving in the US in 1970. It was a new way of performing bronchoscopy, which led to physicians reading about it, and then putting what they read into action. Now – there are high fidelity simulation instruments and models and a lot of experiential learning prefacing the use of new technologies for patients. We have CHEST to thank for being a leader in experiential learning and an international resource for simulation training.
Dr. Richard Irwin, the Editor in Chief for the journal CHEST, and Chair of UMass Memorial Medical Center’s Department of Critical Care, has observed the way patient-focused care has evolved through the years. He will be speaking on this topic at the CHEST 2018 opening session on Sunday, October 7.
During Dr. Irwin’s early years at UMass Memorial, the then chairman of Medicine, Dr. James Dalen, a longtime CHEST member who was about to begin his term as CHEST President, strongly encouraged Dr. Irwin to join the organization. By joining the college, Dr. Irwin was able to form strong connections with other influential chest medicine professionals, such as Dr. Jack Weg, a former CHEST President, and Dr. Alfred Soffer – who was the Editor in Chief of CHEST.
While Dr. Irwin was not yet a member of the CHEST community, the college became instrumental in focusing Dr. Irwin’s academic career because of a manuscript that he and colleagues had been working on, titled Cough. A Comprehensive Review. After submitting the early version of his manuscript to ten different journals and being rejected by each one, Dr. Irwin contacted Dr. Soffer and asked him, if he had the time, could he please read it and offer advice. Dr. Soffer, who had a reputation of being a mentor with endless generosity of his time, reviewed the manuscript and worked with Dr. Irwin on the article, leading to its publication in the Archives of Internal Medicine in 1977. Dr. Soffer’s kindness would lead to the start of Dr. Irwin’s 40-year career of studying cough.
Dr. Irwin has been very influential within the CHEST organization throughout his career. In addition to his years as the Editor in Chief of CHEST, he also served on every major CHEST committee and held the office of CHEST President in 2003-2004. “If you want to join a society that has a family-feel to it and focuses on clinical care and education, then CHEST is the place to be.”
Throughout his years as a physician, Dr. Irwin has been interested in the way physicians learn. During his formative years, he says the way he learned was to “see one, do one, teach one.” He gives the example of the flexible fiber-optic bronchoscope, which was developed in Japan in the late 1960s, arriving in the US in 1970. It was a new way of performing bronchoscopy, which led to physicians reading about it, and then putting what they read into action. Now – there are high fidelity simulation instruments and models and a lot of experiential learning prefacing the use of new technologies for patients. We have CHEST to thank for being a leader in experiential learning and an international resource for simulation training.